These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32783068)

  • 21. MicroRNA-137 targets EZH2 to exert suppressive functions in uveal melanoma via regulation of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
    Zhang J; Liu G; Jin H; Li X; Li N; Yin Q; Hu R
    J BUON; 2021; 26(1):173-181. PubMed ID: 33721449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.
    Herlihy N; Dogrusöz M; van Essen TH; Harbour JW; van der Velden PA; van Eggermond MC; Haasnoot GW; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1447-58. PubMed ID: 25593028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of microRNA-130a represses uveal melanoma cell migration and invasion through inactivation of the Wnt/β-catenin signaling pathway by downregulating USP6.
    Wu S; Han M; Zhang C
    Cancer Gene Ther; 2022 Jul; 29(7):930-939. PubMed ID: 34522027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA HOXA11-AS Exerts Oncogenic Functions by Repressing p21 and miR-124 in Uveal Melanoma.
    Lu Q; Zhao N; Zha G; Wang H; Tong Q; Xin S
    DNA Cell Biol; 2017 Oct; 36(10):837-844. PubMed ID: 28749709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genetic basis of uveal melanoma.
    Nielsen M; Dogrusöz M; Bleeker JC; Kroes WG; van Asperen CA; Marinkovic M; Luyten GP; Jager MJ
    J Fr Ophtalmol; 2015 Jun; 38(6):516-21. PubMed ID: 25976137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
    Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
    Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma.
    Yang C; Wang R; Hardy P
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced expression of son of sevenless homolog 1 is predictive of poor prognosis in uveal malignant melanoma patients.
    Wang YS; Wu L
    Ophthalmic Genet; 2019 Feb; 40(1):22-28. PubMed ID: 30714452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future perspectives of uveal melanoma blood based biomarkers.
    Beasley AB; Chen FK; Isaacs TW; Gray ES
    Br J Cancer; 2022 Jun; 126(11):1511-1528. PubMed ID: 35190695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
    Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
    Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IsomiRs and tRNA-derived fragments are associated with metastasis and patient survival in uveal melanoma.
    Londin E; Magee R; Shields CL; Lally SE; Sato T; Rigoutsos I
    Pigment Cell Melanoma Res; 2020 Jan; 33(1):52-62. PubMed ID: 31283110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel four‑snoRNA signature for predicting the survival of patients with uveal melanoma.
    Yi Q; Zou WJ
    Mol Med Rep; 2019 Feb; 19(2):1294-1301. PubMed ID: 30569172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circ_0119872 promotes uveal melanoma development by regulating the miR-622/G3BP1 axis and downstream signalling pathways.
    Liu S; Chen L; Chen H; Xu K; Peng X; Zhang M
    J Exp Clin Cancer Res; 2021 Feb; 40(1):66. PubMed ID: 33579337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma.
    Pan H; Ni H; Zhang L; Xing Y; Fan J; Li P; Li T; Jia R; Ge S; Zhang H; Fan X
    Tumour Biol; 2016 Oct; 37(10):13533-13543. PubMed ID: 27468714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OSuvm: An interactive online consensus survival tool for uveal melanoma prognosis analysis.
    Wang F; Wang Q; Li N; Ge L; Yang M; An Y; Zhang G; Dong H; Ji S; Zhu W; Guo X
    Mol Carcinog; 2020 Jan; 59(1):56-61. PubMed ID: 31646691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
    Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
    Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
    Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in Molecular and Genetic Research on Uveal Melanoma.
    Fuentes-Rodriguez A; Mitchell A; Guérin SL; Landreville S
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N
    Wang T; Bai J; Zhang Y; Xue Y; Peng Q
    Front Immunol; 2022; 13():918522. PubMed ID: 36003405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
    Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.